In the SURMOUNT-1 trials, individuals who received tirzepatide reported gastrointestinal side effects such as nausea, vomiting, and constipation
Bricogne, G
Our team continuously evaluates and refines products to meet the highest scientific standards, ensuring precision, reliability, and integrity in every peptide and bio-optimized wellness formulation we develop
We are paying close attention to misleading claims being made by telehealth and pharma companies across all media platforms and taking swift action
39(4): 51426 Mitchell SC, Zhang AQ, Smith RL
While I was bearish on PEOs and companies w exposure to employee benefit plans like Insperity (NSP US) , I figured one could go long HMOs for the long term benefits (whoever took the biggest hit in the short term on paying for GLP-1s would ultimately reap the biggest reward in the long term on a healthier customer base)